| Filed On | Filing |
|---|---|
| 12 May 2022 |
Form 3: Bradrick Brittany, Director
No securities owned |
| 24 Mar 2022 |
Form 3: Lim Juhyun, Director
No securities owned |
| 14 Dec 2020 |
Form 3: Brennan Nora, Director
No securities owned |
| 27 Apr 2020 |
Form 3: Fischer Seth H. Z., Director
No securities owned |
| 02 Jul 2019 |
Form 3: Czerepak Elizabeth, Director
No securities owned |
| 21 Jun 2019 |
Form 3: Lebel Francois, Chief Medical Officer
Holds 70,250 shares of Common Stock, $0.001 par value |
| 14 Nov 2018 |
Form 3: Vacirca Jeff L, Director
Holds 10,300 shares of Common Stock, $0.001 par value |
| 18 Jun 2018 |
Form 3: Welles Bernice R, Director
No securities owned |
| 18 Jun 2018 |
Form 3: McGahan Keith M, SVP and Chief Legal Officer
No securities owned |
| 05 Mar 2018 |
Form 3: Ashton William, Director
No securities owned |
| 27 Dec 2017 |
Form 3: Riga Thomas J, Chief Operating Officer
Holds 151,696 shares of Common Stock, $0.001 par value |
| 25 Sep 2014 |
Form 3: Spectrum Pharmaceuticals Inc, 10% owner and 1 other · CASI Pharmaceuticals, Inc (DE)
Holds 3,228,627 shares of Common Stock |
| 02 Jul 2013 | Form 3: Vyas Dolatrai, Director |
| 01 Jul 2013 |
Form 3: Cohen Raymond W, Director
No securities owned |
| 05 Jun 2013 |
Form 3: Gustafson Kurt A, EVP & Chief Financial Officer
No securities owned |
| 24 Apr 2013 |
Form 3: Turgeon Joseph W., Chief Commercial Officer
Holds 25,000 shares of Common Stock, $0.001 Par Value |
| 24 Apr 2013 |
Form 3: Allen Lee F Md PhD, Chief Medical Officer
Holds 30,000 shares of Common Stock, $0.001 Par Value |
| 11 Sep 2012 |
Form 3: Keller Joseph Kenneth, EVP & Chief Operating Officer
Holds 8,000 shares of Common Stock, $.001 Par Value |
| 06 Sep 2012 |
Form 3: Spectrum Pharmaceuticals Inc, 10% owner and 1 other · ALLOS THERAPEUTICS INC
Holds 117,769,357 shares of Common Stock |
| 03 Apr 2012 |
Form 3: Gagnon Gilles, Director
Holds 25,000 shares of Common Stock, $.001 Par Value |
Loading...